These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
508 related articles for article (PubMed ID: 16194583)
1. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Villa LL Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583 [TBL] [Abstract][Full Text] [Related]
2. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review. Ault KA Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901 [TBL] [Abstract][Full Text] [Related]
3. Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines. Mandic A J BUON; 2012; 17(3):422-7. PubMed ID: 23033276 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccines. Stanley MA Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and natural history of genital human papillomavirus infection. Weaver BA J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554 [TBL] [Abstract][Full Text] [Related]
9. Vaccines for preventing HPV-related anogenital infection and neoplasia. Ferris DG J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555 [TBL] [Abstract][Full Text] [Related]
10. Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Williamson AL; Passmore JA; Rybicki EP Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392 [TBL] [Abstract][Full Text] [Related]
11. HPV vaccines. Stanley M Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Paavonen J Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244 [TBL] [Abstract][Full Text] [Related]
13. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. Arbyn M; Dillner J J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503 [TBL] [Abstract][Full Text] [Related]
14. Correlating immunity with protection for HPV infection. Frazer I Int J Infect Dis; 2007 Nov; 11 Suppl 2():S10-6. PubMed ID: 18162240 [TBL] [Abstract][Full Text] [Related]
15. Chapter 12: Prophylactic HPV vaccines: underlying mechanisms. Stanley M; Lowy DR; Frazer I Vaccine; 2006 Aug; 24 Suppl 3():S3/106-13. PubMed ID: 16949996 [TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Adams M; Jasani B; Fiander A Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517 [TBL] [Abstract][Full Text] [Related]
17. A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. Ault KA; Giuliano AR; Edwards RP; Tamms G; Kim LL; Smith JF; Jansen KU; Allende M; Taddeo FJ; Skulsky D; Barr E Vaccine; 2004 Aug; 22(23-24):3004-7. PubMed ID: 15297048 [TBL] [Abstract][Full Text] [Related]
18. Vaccination strategies for the prevention of cervical cancer. Maclean J; Rybicki EP; Williamson AL Expert Rev Anticancer Ther; 2005 Feb; 5(1):97-107. PubMed ID: 15757442 [TBL] [Abstract][Full Text] [Related]
19. Developing an HPV vaccine to prevent cervical cancer and genital warts. Bryan JT Vaccine; 2007 Apr; 25(16):3001-6. PubMed ID: 17289220 [TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccines. Breitburd F; Coursaget P Semin Cancer Biol; 1999 Dec; 9(6):431-44. PubMed ID: 10712890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]